Adjunctive inhaled insulin before meals improved glycaemic control more than adjunctive metformin in type 2 diabetes mellitus

Affiliations

Comment

Yogish C Kudva et al. Evid Based Med. 2006 Dec.

. 2006 Dec;11(6):176.

doi: 10.1136/ebm.11.6.176.

No abstract available

Comment on

Adjunctive inhaled insulin before meals improved glycemic control more than adjunctive metformin in type 2 diabetes mellitus.
Kudva YC, Basu A. Kudva YC, et al. ACP J Club. 2006 Nov-Dec;145(3):67. ACP J Club. 2006. PMID: 17080979 No abstract available.
Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
Dupre J. Dupre J. Regul Pept. 2005 Jun 15;128(2):149-57. doi: 10.1016/j.regpep.2004.06.003. Regul Pept. 2005. PMID: 15780434 Review.
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.
Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M. Barnett AH, et al. Diabetes Care. 2006 Aug;29(8):1818-25. doi: 10.2337/dc05-1880. Diabetes Care. 2006. PMID: 16873786 Clinical Trial.
Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
Hausmann M, Dellweg S, Osborn C, Heinemann L, Buchwald A, Rosskamp R, Genova P, Heise T. Hausmann M, et al. Diabetes Obes Metab. 2006 Sep;8(5):574-80. doi: 10.1111/j.1463-1326.2006.00647.x. Diabetes Obes Metab. 2006. PMID: 16918593 Clinical Trial.
Inhaled insulin: Exubera.
Odegard PS, Capoccia KL. Odegard PS, et al. Ann Pharmacother. 2005 May;39(5):843-53. doi: 10.1345/aph.1E522. Epub 2005 Apr 12. Ann Pharmacother. 2005. PMID: 15827072 Review.